Activist Elliott Builds Big Stake in Life-Science Tools Supplier Bio-Rad
Elliott also has a stake in German lab-equipment supplier Sartorius, where Bio-Rad is also an investor.
----
Apple Is Making Hit Products and High Profits From Imperfect Chips
The company's popular, $599 Neo laptop is just one of dozens of Apple devices that use lower-performing processors.
----
Samsung Management, Union Resume Talks to Avoid Strike
Both sides were under pressure to reach a deal after South Korea's government warned that it could invoke emergency-mediation powers to force a settlement if negotiations fail.
----
Rival Airlines Are Carving Up Spirit's Routes and Airport Slots
Budget carriers like Breeze, Allegiant and Frontier are swooping in on Spirit's former routes as well as circling its valuable takeoff and landing slots at bigger airports.
----
Tesla Just Raised Its EV Prices. Here's Why.
Some Model Y trims in the U.S. just went up by $1,000. That's curious.
----
Walmart and Target are about to show just how much shopping habits have changed due to the Iran war
Walmart has said that customers start to cut spending when gas prices hit $4.50 to $5 a gallon.
----
NextEra Energy Near Deal for Rival Utility Dominion
Agreement could come as soon as Monday, assuming talks don't fall apart.
----
The Messy Courtroom Drama Over AI's Biggest Breakup
The legal showdown between Elon Musk and OpenAI exposed the personal and financial fault lines beneath Silicon Valley's defining boom.
----
Federal Prosecutors Probe BlackRock Private-Credit Fund
A publicly traded BlackRock fund known as TCPC has been marred by write-downs and poor performance.
----
SpaceX Is Aiming to Go Public on June 12 in What Stands to Be Biggest IPO Ever
Elon Musk's rocket company is expected to make its IPO paperwork public next week.
----
Mercedes-Benz CEO Says Carmaker Is Willing to Enter Defense Production
The remarks come as the German manufacturing sector seeks to recast itself as a major player in the West's defense arsenal.
----
20 People in Japan Died After Taking Amgen Drug
Kissei Pharmaceutical, which sells the rare immune-disease drug in Japan, warned doctors to stop prescribing it to new patients.
----
Berkshire Invests in Delta Again During Abel's First Quarter as CEO
The company exited positions in Amazon, Mastercard, Visa and UnitedHealth, among many others.
----
Right-to-Repair Advocates Are Taking On Deere Again-This Time in Construction
The company agreed recently to pay $99 million in a "right-to-repair" lawsuit with farmers.
----
Bill Ackman's Pershing Square Bets on Microsoft's AI Ambitions With New Stake
The investor says the tech company is underpriced, and he will disclose the stake in regulatory filings later Friday.
(END) Dow Jones Newswires
May 17, 2026 23:00 ET (03:00 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.